We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPR icon
676
Tapestry
TPR
$30.3B
$6.08M 0.01%
47,573
+12,251
+35% +$1.4M
NVR icon
677
NVR
NVR
$17.1B
$5.99M 0.01%
822
-29
-3% -$217K
PRQR icon
678
ProQR Therapeutics
PRQR
$244M
$5.96M 0.01%
2,950,676
+651,853
+28% +$1.52M
GLD icon
679
SPDR Gold Trust
GLD
$131B
$5.94M 0.01%
14,979
-4,831
-24% -$1.84M
VIPS icon
680
Vipshop
VIPS
$7.26B
$5.79M 0.01%
327,248
-34,011
-9% -$654K
NBIX icon
681
Neurocrine Biosciences
NBIX
$18.2B
$5.68M 0.01%
40,016
-50,029
-56% -$7.25M
EVRG icon
682
Evergy
EVRG
$19.4B
$5.66M 0.01%
78,056
-1,868
-2% -$142K
NSPR icon
683
InspireMD
NSPR
$31.4M
$5.65M 0.01%
3,173,364
+692,247
+28% +$1.44M
VRSN icon
684
VeriSign
VRSN
$26.3B
$5.64M 0.01%
23,219
-665
-3% -$167K
FOX icon
685
Fox Class B
FOX
$22.1B
$5.63M 0.01%
86,738
+271
+0.3% +$15.8K
LNT icon
686
Alliant Energy
LNT
$18.6B
$5.63M 0.01%
86,551
+452
+0.5% +$30.3K
CPA icon
687
Copa Holdings
CPA
$5.56B
$5.62M 0.01%
46,611
-9,689
-17% -$1.19M
TSHA icon
688
Taysha Gene Therapies
TSHA
$1.61B
$5.62M 0.01%
+1,021,063
New +$4.96M
EME icon
689
Emcor
EME
$29.9B
$5.6M 0.01%
9,148
+2,384
+35% +$1.54M
JBL icon
690
Jabil
JBL
$30.1B
$5.53M 0.01%
24,267
-1,023
-4% -$218K
CYH icon
691
Community Health Systems
CYH
$382M
$5.53M 0.01%
1,772,139
+342,359
+24% +$1.15M
MYGN icon
692
Myriad Genetics
MYGN
$476M
$5.45M 0.01%
885,801
+246,748
+39% +$1.79M
HRL icon
693
Hormel Foods
HRL
$14.2B
$5.4M 0.01%
227,774
+8,838
+4% +$206K
BXSL icon
694
Blackstone Secured Lending
BXSL
$5.36B
$5.36M 0.01%
203,521
+29,249
+17% +$785K
AMH icon
695
American Homes 4 Rent
AMH
$12.1B
$5.28M 0.01%
164,491
+6,214
+4% +$199K
SMIN icon
696
iShares MSCI India Small-Cap ETF
SMIN
$750M
$5.28M 0.01%
75,502
-11,598
-13% -$837K
AQST icon
697
Aquestive Therapeutics
AQST
$452M
$5.23M 0.01%
809,203
+184,203
+29% +$1.15M
TEVA icon
698
Teva Pharmaceuticals
TEVA
$40.4B
$5.21M 0.01%
167,009
-655,837
-80% -$16.2M
KNF icon
699
Knife River
KNF
$4.33B
$5.09M 0.01%
72,306
-40,336
-36% -$2.83M
BEN icon
700
Franklin Resources
BEN
$16.8B
$5.09M 0.01%
212,862
-11,077
-5% -$254K
26 27
28
29 30

Similar funds

Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.